Mangoceuticals, Inc. (MGRX) Earnings History
Annual and quarterly earnings data from 2021 to 2024
Loading earnings history...
MGRX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MGRX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 61.7% | -1294.4% | -1413.6% |
| 2023 | 59.0% | -1260.3% | -1259.4% |
| 2022 | 54.3% | -22279.7% | -22352.1% |
| 2021 | - | - | - |
Download Data
Export MGRX earnings history in CSV or JSON format
Free sign-in required to download data
Mangoceuticals, Inc. (MGRX) Earnings Overview
As of May 6, 2026, Mangoceuticals, Inc. (MGRX) reported trailing twelve-month net income of -$20M, reflecting +48.7% year-over-year growth. The company earned $-1.72 per diluted share over the past four quarters, with a net profit margin of -1413.6%.
Looking at the long-term picture, MGRX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$17,701 in fiscal 2021.
Mangoceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HIMS ($128M net income, 5.5% margin), MNMD (-$184M net income), AMWL (-$88M net income, -38.4% margin), MGRX has room to improve margins relative to the peer group. Compare MGRX vs HIMS →
MGRX Earnings vs Peers
Earnings metrics vs comparable public companies
MGRX Historical Earnings Data (2021–2024)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$9M | +5.5% | -$8M | $-4.40 | -1413.6% | -1294.4% |
| 2023 | -$9M | -361.1% | -$9M | $-8.58 | -1259.4% | -1260.3% |
| 2022 | -$2M | -11187.8% | -$2M | $-1.73 | -22352.1% | -22279.7% |
| 2021 | $-17,701 | - | $-17,520 | $-0.02 | - | - |
See MGRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MGRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MGRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMGRX — Frequently Asked Questions
Quick answers to the most common questions about buying MGRX stock.
Is MGRX growing earnings?
MGRX EPS is $-1.72, with earnings growth accelerating to +48.7%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-20M.
What are MGRX's profit margins?
Mangoceuticals, Inc. net margin is -1413.6%, with operating margin at -1294.4%. Below-average margins reflect competitive or cost pressures.
How consistent are MGRX's earnings?
MGRX earnings data spans 2021-2024. The accelerating earnings trend is +48.7% YoY. Historical data enables comparison across business cycles.